SCHEMBL29588049

SCHEMBL29588049

C=C(CC(=O)OC1(c2ccc(SC(F)(F)F)cc2)CCC1)C(=O)OCC(=O)OCC(Cl)(Cl)Cl

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24393966 0.91 PDE2A (0.32) PDE2A
SCHEMBL29587970 0.87 LMNA (0.32) —
SCHEMBL26929235 0.87 PDE2A (0.36) PDE2A
SCHEMBL26929222 0.85 — —
SCHEMBL26929238 0.85 DRD2 (0.34) —
SCHEMBL29588742 0.84 PDE2A (0.38) PDE2A
SCHEMBL24393967 0.82 PDE2A (0.37) PDE2A
SCHEMBL24393969 0.82 PDE2A (0.35) PDE2A
SCHEMBL25043526 0.81 LMNA (0.32) —
SCHEMBL24394133 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4237408-A1 ITACONIC ACID DERIVATIVES Sitryx Therapeutics Limited (GB) 2023-09-06 — — EP claimed
WO-2022090723-A1 ITACONIC ACID DERIVATIVES SITRYX THERAPEUTICS LIMITED (GB) 2022-05-05 — — WO claimed
EP-4237408-A1 ITACONIC ACID DERIVATIVES Sitryx Therapeutics Limited (GB) 2023-09-06 — — EP disclosed
WO-2022090723-A1 ITACONIC ACID DERIVATIVES SITRYX THERAPEUTICS LIMITED (GB) 2022-05-05 — — WO disclosed
Send feedback